Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$1.41 USD
+0.02 (1.44%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.52 +0.11 (7.80%) 7:02 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/12/24 |
---|---|
Current Quarter | -0.27 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | 44.70% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.65 |
Next Year | -0.87 |
EPS (TTM) | -3.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 32.96M | 28.73M | 90.05M | 152.87M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 49.11M | 30.30M | 104.19M | 179.24M |
Low Estimate | 16.80M | 27.16M | 75.90M | 126.50M |
Year ago Sales | 34.75M | 19.95M | 84.51M | 90.05M |
Year over Year Growth Est. | -5.17% | 44.01% | 6.55% | 69.77% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.27 | -0.61 | -2.65 | -0.87 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.27 | -0.61 | -2.65 | -0.87 |
High Estimate | -0.27 | -0.61 | -2.65 | -0.87 |
Low Estimate | -0.27 | -0.61 | -2.65 | -0.87 |
Year ago EPS | -0.94 | -0.53 | -8.47 | -2.65 |
Year over Year Growth Est. | 71.28% | -15.09% | 68.71% | 67.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.27 | -0.61 | -2.65 | -0.87 |
7 Days Ago | -0.27 | -0.61 | -2.65 | -0.87 |
30 Days Ago | -1.21 | -1.21 | -2.65 | -0.87 |
60 Days Ago | -1.36 | -1.30 | -3.27 | -2.56 |
90 Days Ago | -1.36 | -1.30 | -3.27 | -2.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.61 | -2.65 | -0.87 |
Zacks Consensus Estimate | -0.27 | -0.61 | -2.65 | -0.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -1.03 | -0.53 | -0.94 | NA |
Estimate | -1.32 | -2.03 | NA | -3.53 | NA |
Difference | 0.59 | 1.00 | NA | 2.59 | 1.39 |
Surprise | 44.70% | 49.26% | NA | 73.37% | 55.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more